HighTide Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-381.79	-939.31	-190.24	-221.15
Depreciation & Amortization	5.9	1.83	1.27	1.59
Loss (Gain) From Sale of Assets	0.21	-	-	0
Loss (Gain) From Sale of Investments	6.11	522.16	-23.24	93.66
Stock-Based Compensation	96.93	93.49	25.62	7.3
Other Operating Activities	-29.77	-23.31	-10.58	14.72
Change in Accounts Payable	20.97	8.81	15.61	-0.81
Change in Unearned Revenue	-	-0.33	-3.89	3.42
Change in Other Net Operating Assets	-17.03	-19.96	13.07	10.72
Operating Cash Flow	-298.47	-356.62	-172.38	-90.55
Capital Expenditures	-4.29	-0.8	-0.18	-1.75
Sale of Property, Plant & Equipment	-	-	-	0
Investment in Securities	-78.19	293.18	-423.92	-
Other Investing Activities	27.81	22.98	8.44	3.33
Investing Cash Flow	-54.66	315.36	-415.66	1.59
Short-Term Debt Issued	61.83	5	15	10
Total Debt Issued	61.83	5	15	10
Short-Term Debt Repaid	-8.44	-9.65	-13.85	-187.52
Long-Term Debt Repaid	-2.86	-0.98	-0.99	-1.27
Total Debt Repaid	-11.3	-10.63	-14.84	-188.79
Net Debt Issued (Repaid)	50.53	-5.63	0.16	-178.79
Issuance of Common Stock	-	252.9	-	-
Other Financing Activities	-1.53	113.84	-1.26	-18.41
Financing Cash Flow	49	361.1	46.03	493.98
Foreign Exchange Rate Adjustments	6.67	15.32	49.76	-6.99
Net Cash Flow	-297.46	335.17	-492.24	398.04
Free Cash Flow	-302.75	-357.42	-172.56	-92.29
Free Cash Flow Per Share	-0.67	-1.38	-0.68	-2.19
Cash Interest Paid	1.53	0.4	0.3	0.31
Cash Income Tax Paid	0.53	0.11	0.02	0.01
Levered Free Cash Flow	-177	-194.44	-86.71	-
Unlevered Free Cash Flow	-176.04	-194.19	-86.45	-
Change in Net Working Capital	-3.39	8.56	-28.14	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.